Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SNDK
626
Sandisk
SNDK
$252B
| $69.9M | 0.02% |
294,559
+157,844
| +115% | +$31.6M |
2025 Q1
3 quarters
|
|
627
Hasbro
HAS
$12.6B
| $69.9M | 0.02% |
851,937
+177,785
| +26% | +$13.9M |
2013 Q2
50 quarters
|
|
628
Wayfair
W
$13.9B
| $69.4M | 0.02% |
691,003
+198,116
| +40% | +$19.1M |
2014 Q4
44 quarters
|
|
629
Delta Air Lines
DAL
$55.3B
| $69.3M | 0.02% |
998,493
-479,372
| -32% | -$30M |
2013 Q2
50 quarters
|
|
630
Qiagen
QGEN
$9.24B
| $69.2M | 0.02% |
1,539,762
+452,831
| +42% | +$20.9M |
2017 Q1
35 quarters
|
|
631
Keysight
KEYS
$65.5B
| $69M | 0.02% |
339,490
-20,709
| -6% | -$3.84M |
2014 Q4
44 quarters
|
|
632
PUT
Dick's Sporting Goods
DKS
$13.4B
| $68.5M | 0.02% |
345,800
-881,000
| -72% | -$192M |
2024 Q3
5 quarters
|
|
633
CALL
Crocs
CROX
$5.66B
| $68.4M | 0.02% |
800,000
+170,000
| +27% | +$14.2M |
2024 Q4
4 quarters
|
|
634
Pinnacle West Capital
PNW
$11.6B
| $68.1M | 0.02% |
768,045
+7,672
| +1% | +$687K |
2013 Q2
50 quarters
|
|
635
Flex
FLEX
$43.1B
| $68.1M | 0.02% |
1,126,713
+125,045
| +12% | +$7.72M |
2013 Q4
48 quarters
|
|
636
PUT
ExxonMobil
XOM
$674B
| $67.8M | 0.02% |
563,300
-3,300
| -0.6% | -$383K |
2024 Q3
5 quarters
|
|
637
Viatris
VTRS
$20.2B
| $67.6M | 0.02% |
5,427,865
+52,111
| +1% | +$562K |
2022 Q1
15 quarters
|
|
|
ABVX
638
CALL
Abivax
ABVX
$8.11B
| $67.4M | 0.02% |
+500,000
| New | +$54.6M |
2025 Q4
0 quarters
|
|
|
ABVX
639
PUT
Abivax
ABVX
$8.11B
| $67.4M | 0.02% |
+500,000
| New | +$54.6M |
2025 Q4
0 quarters
|
|
640
PUT
Applied Materials
AMAT
$429B
| $67.4M | 0.02% |
262,300
-236,400
| -47% | -$56.7M |
2024 Q3
5 quarters
|
|
|
ECHO
641
CALL
EchoStar
ECHO
$27.4B
| $67.4M | 0.02% |
620,000
+334,500
| +117% | +$27.2M |
2024 Q2
6 quarters
|
|
642
Indivior Pharmaceuticals
INDV
$4.21B
| $67.4M | 0.02% |
1,878,157
-246,396
| -12% | -$7.52M |
2023 Q2
10 quarters
|
|
643
Eversource Energy
ES
$24.3B
| $67M | 0.02% |
994,966
-450,907
| -31% | -$31.7M |
2013 Q2
50 quarters
|
|
644
Weatherford International
WFRD
$5.7B
| $67M | 0.02% |
855,752
+784,237
| +1,097% | +$56.9M |
2022 Q1
15 quarters
|
|
645
Enbridge
ENB
$102B
| $66.9M | 0.02% |
1,399,049
+604,547
| +76% | +$28.9M |
2013 Q2
50 quarters
|
|
646
Ionis Pharmaceuticals
IONS
$7.24B
| $66.7M | 0.02% |
842,871
+128,823
| +18% | +$9.7M |
2013 Q2
50 quarters
|
|
|
647
CALL
Delta Air Lines
DAL
$55.3B
| $66.5M | 0.02% |
957,800
+487,800
| +104% | +$30.5M |
2024 Q2
6 quarters
|
|
648
Evergy
EVRG
$18.3B
| $66.4M | 0.02% |
916,358
+163,373
| +22% | +$12.4M |
2018 Q2
30 quarters
|
|
649
CALL
AB InBev
BUD
$145B
| $66.3M | 0.02% |
1,035,400
| – | – |
2023 Q4
8 quarters
|
|
650
CALL
VanEck Junior Gold Miners ETF
GDXJ
$8.39B
| $66.3M | 0.02% |
582,500
+557,500
| +2,230% | +$57.6M |
2025 Q3
1 quarter
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.